The company intends to use the funds to conduct clinical trials for the lead drug candidate in its immuno-oncology program, KAN-001, and advance its commercial partnerships.

Company Information

Company Status

Private & Independent

Industry

Biopharmaceutical

Mailing Address

1 Deer Park Drive Suite G-5
Monmouth Junction, NJ 08852
USA

Phone

(617) 435-4900

Website

www.kanvasbio.com

Email Address

[email protected]

Overview

We are a young startup building new tools and methods to image microbes and describe their environments.

Profile

Social Media

Kanvas Biosciences Company Twitter Account

Company News

Facebook

YouTube

Management Team

Title

Name

Email & Social

Chief Executive Officer

Hao Shi

Browse more venture capital transactions:

Prev: 5/6/2026: meteoviva venture capital transaction
Next: 5/6/2026: Genesis AI venture capital transaction

Share this article

About Our Venture Capital Transactions Database

Our team works diligently to report on funding rounds that are announced publicly. VC investment data records on this site are sourced from news reports and company announcements. The information is sourced from VentureDeal.com, an affiliated venture.

Additional Resources for Entrepreneurs

Lists of Venture Capital and Private Equity Firms

Franchise Opportunities

Contributors

Business Glossary